# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, I...
Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and maintains $33 price target.
RBC Capital analyst Sean Dodge reiterates Evolent Health (NYSE:EVH) with a Outperform and maintains $42 price target.
Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR.
- Reuters Citing Sources
JP Morgan analyst Anne Samuel maintains Evolent Health (NYSE:EVH) with a Overweight and raises the price target from $36 to ...